3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
2
Colorectal Neoplasms
2
Prostatic Neoplasms
1
Motor Activity
1
Eye Diseases
1
Cognitive Dysfunction
1
Cardiovascular Diseases
1
Interventions
Aspirin
2
sofosbuvir-velpatasvir drug combination
1
palbociclib
1
beta Carotene
1
Vitamin E
1
Vitamin D
1
Rivaroxaban
1
Referral and Consultation
1
Progestins
1
Lysine Acetyltransferase 5
1
Hormone Replacement Therapy
1
Health Information Exchange
1
Geritol
1
Ethanol
1
Estrogens
1
Estrogen Replacement Therapy
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Calcium
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiovascular Diseases
×
Geritol
×
Gastrointestinal
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled